Chris Freeman - 12 Mar 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Commercial Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Chris Freeman
Issuer symbol
GH
Transactions as of
12 Mar 2025
Transactions value $
$0
Form type
4
Filing time
13 Mar 2025, 16:40:18 UTC
Previous filing
04 Mar 2025
Next filing
18 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Stock Option (Right to Buy) Award $0 +23,145 $0 23,145 12 Mar 2025 Common Stock 23,145 $43.1 Direct F1
transaction GH Restricted Stock Units Award $0 +15,430 $0 15,430 12 Mar 2025 Common Stock 15,430 $0 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a stock option award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.
F2 This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
F3 Not applicable for Restricted Stock Units.